Avidity Biosciences Inc’s recently made public that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $27549.0 on Jun 17 ’25. In the deal valued at $30.24 per share,911 shares were sold. As a result of this transaction, Gallagher Kathleen P. now holds 50,392 shares worth roughly $1.43 million.
Then, KATHLEEN GALLAGHER bought 911 shares, generating $27,148 in total proceeds.
Before that, Flanagan W. Michael sold 20,000 shares. Avidity Biosciences Inc shares valued at $657,694 were divested by the Chief Scientific Officer at a price of $32.88 per share. As a result of the transaction, Flanagan W. Michael now holds 80,195 shares, worth roughly $2.28 million.
Bernstein initiated its Avidity Biosciences Inc [RNA] rating to an Outperform in a research note published on June 24, 2025; the price target was $50. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid June with a ‘”an Outperform”‘ rating. Raymond James began covering RNA with “Strong buy” recommendation on June 11, 2025. Citigroup started covering the stock on March 13, 2025. It rated RNA as “a Buy”.
Price Performance Review of RNA
On Tuesday, Avidity Biosciences Inc [NASDAQ:RNA] saw its stock jump 0.21% to $28.46. Over the last five days, the stock has lost -4.72%. Avidity Biosciences Inc shares have fallen nearly -29.80% since the year began. Nevertheless, the stocks have fallen -2.13% over the past one year. While a 52-week high of $56.00 was reached on 06/09/25, a 52-week low of $21.51 was recorded on 04/09/25.
Levels Of Support And Resistance For RNA Stock
The 24-hour chart illustrates a support level at 27.62, which if violated will result in even more drops to 26.79. On the upside, there is a resistance level at 29.38. A further resistance level may holdings at 30.30.
How much short interest is there in Avidity Biosciences Inc?
A steep rise in short interest was recorded in Avidity Biosciences Inc stocks on 2025-06-13, growing by 0.56 million shares to a total of 16.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 15.79 million shares. There was a rise of 3.41%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 12, 2025 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $72 price target.
